Tesamorelin Description: A growth hormone-releasing peptide that targets visceral fat, especially in the abdominal area, while supporting metabolic health
Importantly, AOD-9604 does not appear to bind to the growth hormone receptor itself in cell-binding studies
Supporting a dominant role for diet composition in establishing the Firmicutes : Bacteroidetes ratio, previous work has shown that mice maintained on a high-fat diet had a similar cecal Firmicutes : Bacteroidetes ratio to those maintained on a high-carbohydrate diet 77
Purity tested Endotoxin tested Heavy metals tested A synthetic dual agonist at the GIP and GLP-1 receptors, developed by Eli Lilly
Some physicians combine these approaches for patients who benefit from both appetite control and enhanced fat metabolism, though close medical monitoring is essential
However, no published research directly compares continuous versus cycled protocols